Trial · NCT03191721
Triclosan Toothpaste in the Maintenance Phase of Peri-implantitis Treatment.
NCT03191721, Phase 3, Completed, University of Guarulhos
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Triclosan Toothpaste in the Maintenance Phase of Peri-implantitis Treatment. Trials, record NCT03191721. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03191721
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Triclosan Toothpaste in the Maintenance Phase of Peri-implantitis Treatment.
- NCT number
- NCT03191721
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 102 participants, actual
- Lead sponsor
- University of Guarulhos
- Conditions
- Peri-Implantitis, Periodontal Diseases
- Interventions
- Surgical anti-infective therapy, Periodontal treatment, Oral Hygiene Instruction, Triclosan toothpaste, Fluoride toothpaste, Regular maintenance program
- First posted
- 2017-06-19
- Last updated
- 2017-06-19
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical Attachment Level (CAL) at 24 months. | 24 months | Difference between groups for the change in Clinical Attachment Level (CAL) from baseline to 24 months. |
| Secondary | Probing Depth (PD) ≥ 5 mm. | Baseline, 3, 6, 12, 18, 24 months. | Number of sites with Probing Depth (PD) ≥ 5 mm, evaluated in all volunteers. |
| Secondary | PD ≥ 6 mm. | Baseline, 3, 6, 12, 18, 24 months. | Number of sites with PD ≥ 6 mm, evaluated in all volunteers. |
| Secondary | PD ≥ 7 mm. | Baseline, 3, 6, 12, 18, 24 months. | Number of sites with PD ≥ 7 mm, evaluated in all volunteers. |
| Secondary | Full-mouth PD. | Baseline, 3, 6, 12, 18, 24 months. | Mean of the PD evaluated in all the periodontal sites from all volunteers. |
| Secondary | Full-mouth CAL. | Baseline, 3, 6, 12, 18, 24 months. | Mean of the CAL evaluated in all the periodontal sites from all volunteers. |
| Secondary | Bleeding on Probing (BOP). | Baseline, 3, 6, 12, 18, 24 months. | Percentage of sites with bleeding on probing (BOP), evaluated in all volunteers. |
| Secondary | Plaque accumulation. | Baseline, 3, 6, 12, 18, 24 months. | Percentage of sites with plaque accumulation, evaluated in all volunteers. |
| Secondary | Marginal bleeding. | Baseline, 3, 6, 12, 18, 24 months. | Percentage of sites with marginal bleeding. |
| Secondary | Sites gaining CAL ≥ 2mm. | Baseline - 24 months. | Percentage of sites gaining ≥ 2mm of CAL. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers25
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03191721
GET https://conductscience.org/api/trials/v1/NCT03191721/papers?page=2